In order to better understand the mechanism(s) of action of carbamazepine (CBZ), we studied its effects on the increase in [Ca 2 + ] i and [Na + ] i stimulated by glutamate ionotropic receptor agonists, in cultured rat hippocampal neurons, as followed by indo-1 or SBFI fluorescence, respectively. CBZ inhibited the increase in [Ca 2 + ] i stimulated either by glutamate, kainate, a-amino-3-hydroxy-5-methyl-isoxazole-4-propionate (AMPA), or N-methyl-D-aspartate (NMDA), in a concentration-dependent manner. In order to discriminate the effects of CBZ on the activation of glutamate receptors from possible effects on Ca 2 + channels, we determined the inhibitory effects of Ca 2 + channel blockers on [Ca 2 + ] i changes in the absence or in the presence of CBZ. The presence of 1 mM nitrendipine, 0.5 mM v-conotoxin GVIA (v-CgTx GVIA), or of both blockers, inhibited the kainate-stimulated increase in [Ca 2 + ] i by 51.6, 32.9 or 68.7%, respectively. In the presence of both 100 mM CBZ and nitrendipine, the inhibition was similar (54.1%) to that obtained with nitrendipine alone, but in the presence of both CBZ and v-CgTx GVIA, the inhibition was greater (54%) than that caused by v-CgTx GVIA alone. However, CBZ did not inhibit the increase in [Na + ] i stimulated by the glutamate receptor agonists, but inhibited the increase in [Na + ] i due to veratridine. Tetrodotoxin, or MK-801, did not inhibit the influx of Na + stimulated by kainate, indicating that Na + influx occurs mainly through the glutamate ionotropic non-NMDA receptors. Moreover, LY 303070, a specific AMPA receptor antagonist, inhibited the [Na + ] i response to kainate or AMPA by about 70 or 80%, respectively, suggesting that AMPA receptors are mainly involved. Taken together, the results suggest that CBZ inhibits L-type Ca 2 + channels and Na + channels, but does not inhibit activation of glutamate ionotropic receptors.